Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases, Vascular

Explore clinical trials studying Skin Diseases, Vascular. Study availability and eligibility vary by location and protocol.

953 public trials 193 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases, Vascular trial results

Completed

A Study of Lanadelumab (SHP643) in Chinese Participants With Hereditary Angioedema (HAE)

NCT05460325

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • The Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
  • Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology Wuhan, Hubei, China
  • Yantai Yuhuangding Hospital Yantai, Shandong, China
  • Peking Union Medical College Hospital Beijing, China
View Trial Details
Completed

Phase 1b, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Chronic Inducible Urticaria

NCT06050928

Conditions
Chronic Disease, Chronic Inducible Urticaria, Chronic Urticaria, +10 more
Locations
  • Advanced Clinical Research Institute Tampa, Florida, United States
  • Treasure Valley Medical Research Boise, Idaho, United States
  • Allergy & Asthma Specialists, P.S.C. Owensboro, Kentucky, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View all 15 locations
View Trial Details
Completed

A Single Dose, Phase 1 Study of YH35324 in Patients with Various Allergic Diseases

NCT05960708

Conditions
Allergic Disease, Chronic Disease, Chronic Inducible Urticaria, +13 more
Locations
  • Hallym University Sacred Heart Hospital Anyang-si, Gyeonggi-do, South Korea
  • Hallym University Dongtan Sacred Heart Hospital Hwaseong-si, Gyeonggi-do, South Korea
  • CHA Bundang Medical Center Seongnam-si, Gyeonggi-do, South Korea
  • Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
View Trial Details
Completed

Firazyr® Patient Registry (Icatibant Outcome Survey - IOS)

NCT01034969

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • Campbelltown Hospital Campbelltown, New South Wales, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • Medizinische Universität Graz Graz, Austria
  • Faculdade de Medicina Do ABC Santo André, São Paulo, Brazil
View all 74 locations
View Trial Details
Completed

Mepolizumab Long-term Study to Assess Real World Safety and Effectiveness of Eosinophilic Granulomatosis With Polyangiitis (EGPA) in Japan

NCT04551989

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +13 more
Locations
  • GSK Investigational Site Aichi, Japan
  • GSK Investigational Site Gunma, Japan
  • GSK Investigational Site Hyōgo, Japan
  • GSK Investigational Site Hyōgo, Japan
View all 34 locations
View Trial Details

Related conditions